1 not yet recruiting, 1 unknown, 1 withdrawn. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Not yet recruiting 1, Unknown 1, Withdrawn 1 |
Follow Post-thrombotic Syndrome: new trials by email Literature Review of Post-thrombotic Syndrome trials Research Report on Post-thrombotic Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Design and Rationale of the COLT Study Colchicine 0.5 MG Oral Tablet, Placebo - Venous Thrombosis Deep (Limbs), Post-thrombotic Syndrome | Phase 3 | Not yet recruiting | Azienda Sanitaria Locale ASL 6, Livorno | 940 | 2026-06-01 | 2026-02-25 |
| The MUFFIN-PTS Trial Micronized Purified Flavonoid Fraction, Placebo - Post-Thrombotic Syndrome | Phase 3 | Unknown | Sir Mortimer B. Davis - Jewish General Hospital | 88 | 2022-02-04 | 2023-11-30 |
| Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial Recombinant tissue plasminogen activator (rt-PA), Standard Anticoagulation Therapy - Deep Vein Thrombosis, Post-Thrombotic Syndrome | Phase 3 | Withdrawn | University of Colorado, Denver | 2018-07-01 | 2018-08-10 |
Postthrombotic Syndrome (3) · Venous Thrombosis (3) · Inflammation (1) · Thrombosis (1) · Venous Insufficiency (1) · Venous Thromboembolism (1)
Cardiovascular Diseases (3) · Embolism and Thrombosis (3) · Vascular Diseases (3) · Thrombosis (2) · Venous Insufficiency (2) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Thromboembolism (1)
Colchicine (1) · Tablets (1) · Tissue Plasminogen Activator (1)
Azienda Sanitaria Locale ASL 6, Livorno (1) · Sir Mortimer B. Davis - Jewish General Hospital (1) · University of Colorado, Denver (1)
Canada (1)
Jean-Philippe Galanaud, MD, PhD (1) · Marilyn J Manco-Johnson, MD (1) · Susan R Kahn, MD, MSc (1)